CohBar (NASDAQ:CWBR) is merging with privately held personalized cancer vaccine developer Morphogenesis and the combined company is expected to operate under the name TuHURA Biosciences Inc. Under the ...

TAMPA, Fla. (WFLA) – A Tampa company developing a skin cancer vaccine has recently appointed a new CEO who plans to take the company public within the next few months. Dr. James Bianco, an oncologist ...

TAMPA, Fla. (WFLA) – Tampa company Morphogenesis has received a “fast track” designation for its skin cancer vaccination from the United States Food and Drug Administration. Morphogenesis is a ...

CohBar and Morphogenesis will morph into TuHURA Biosciences in an all-stock transaction that will see the newly formed, publicly held company work on addressing the major limitations of existing ...

Tissue engineering—creating a “seed” of tissue that could grow into a functional, life-saving organ—sounds like magic. But it could become technology, thanks in part to the work led by Lance Davidson, ...

A research team found that arginine metabolism has a vital role in regulating gametophore shoot formation in the moss Physcomitrium patens. Arginine metabolism boosts to make a plant body complex, ...

Morphogenesis CEO Jim Bianco talks IPOs, Tampa Bay’s biotech scene and why their “cancer vaccine” isn’t a vaccine at all. Jim Bianco is CEO of Morphogenesis, a Tampa biotechnology company working in ...